Treatments

At the start of May, we posted an update on clinical trials that were evaluating high dose biotin as a treatment for multiple sclerosis. Undertaken by biotechnology company, medDay, the results of these trials...

INTERVIEW WITH DR CHRISTIAN GRUBER – MEDICAL UNIVERSITY OF VIENNA AND UNIVERSITY OF QUEENSLAND BD: Brett Drummond, MStranslate CG: Dr. Christian Gruber, Medical University of Vienna & University...

At the recent American Academy of Neurology (AAN) conference, MedDay provided an update on their trials into the use of their biotin compound (MD1003) as a treatment for multiple sclerosis (MS). In...

AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR REBECCA SPAIN – OREGON HEALTH AND SCIENCES UNIVERSITY (OHSU), VA PORTLAND HEALTH CARE SYSTEM BD: Brett Drummond,...

A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially reverse damage to the optic nerve in people with multiple...

Research Summary: Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis The background Current MS therapies mostly work to suppress...

Research Summary: Regulation of prefrontal cortex myelination by the microbiota The Background In recent times, there has been an increasing focus placed on the role that the gut microbiome (composed of...

Research Summary: Cutting Edge: Integrin a4 is required for regulatory B cell control of experimental autoimmune encephalomyelitis The background For a long time, multiple sclerosis was regarded as an...

INTERVIEW WITH DR TRAVIS STILES – CEO, NOVORON BIOSCIENCE BD: Brett Drummond, MStranslate TS: Dr Travis Stiles, Novoron Bioscience BD:  So welcome everyone to our video today.  This video has come...

Research Summary: Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis The...